Wednesday, October 15, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Health

Dr Reddy’s tablets in US

Fiinews by Fiinews
October 11, 2016
in Health
Reading Time: 1 min read
A A
0
0
SHARES
11
VIEWS
LinkedinShare on Twitter

Dr Reddy’s tablets in US

ECU World Wide

Dr. Reddy’s Laboratories Ltd has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg, and 200 mg, a therapeutic equivalent generic version of Lamictal® ODT (lamotrigine) Orally Disintegrating Tablets in the United States market.

Approved by the U.S. Food & Drug Administration (USFDA), the Lamotrigine Orally Disintegrating Tablets 25 mg, 50 mg, 100 mg, and 200 mg are available in bottle count sizes of 30s.

Lamictal® ODT is a registered trademark of GSK group of companies. fii-news.com

Tags: Dr. Reddy’s Laboratories
ShareTweetShare

Related Posts

Aster DM Healthcare
Health

Technologies: AI, ML, IoT, Metaverse are important for future doctors

by Fiinews
May 25, 2022
0
10

Dr. Moopen sees creation of innovation by technology-medicine collaboration India is on the cusp of a major technological revolution which...

Zifo
Health

Investment: TA invests in Zifo’s deep customer relationships with global industry

by Fiinews
May 10, 2022
0
10

Zifo has a meaningful opportunity to expand and support more organizations in their digital transformation, says Kaur TA Associates has...

Indian nursing council

Projects: India-Sweden to upskill 5,000 nurses across the country

April 21, 2022
10
anlitiks

Investment: Excelra-Anlitiks combine deep scientific domain expertise

April 21, 2022
10
Invested Bank

Investment: INCOR says Rs.1,550m raised for healthcare growth strategy

April 8, 2022
10
MSD

Investment: MSD leads global investors in $162m HealthQuad Fund-II

March 31, 2022
10
SBI YONO
Sabit

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Market: Fintech ecosystems continue expanding
  • Invest: TVS Fund 4 gets CRISIL grading
  • Market: Netcore Cloud to “Do The Impossible”
  • Export: India calls for Spice Standards
  • Invest: India funds Mongolian oil refinery

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.